Derisq
The Definitive AI Report for Predictive Risk Intelligence
Derisq™ by GATC Health delivers validated predictions of safety, efficacy, and risk, helping biopharma succeed faster.
What Derisq Delivers
Decisions with Confidence –
Delivers accurate predictions for safety, efficacy and potential off-target effects—empowering decisions well before trials.
Validated by industry and academia, Derisq sets a new benchmark for predictive intelligence in drug development: 91% specificity, and 86% sensitivity in independent validation at UC Irvine.
Trials Built to Succeed –
400 trillion biological data points analyzed in minutes.
Trusted by biotech and investors – used as an underwriting tool to insure clinical trial outcomes by top global insurer.
Capital Efficiency –
Significant savings in pre-clinical costs.
Prioritize portfolios and direct resources to drug candidates that report the highest probability of success.
Derisq by GATC Health: Confidence Before Commitment
“Derisq is a powerful new tool to help us reduce uncertainty and improve efficiency of research, development, and strategic decisions. It provides an assessment based on simulation of human biology of how drug candidates should be expected to perform clinical trials.”
President and Chief Executive Officer,
Member of the Board at Lisata Therapeutics, Inc.